• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence.

作者信息

Hoshida Yujin

出版信息

J Hepatol. 2009 Nov;51(5):842-4. doi: 10.1016/j.jhep.2009.08.003. Epub 2009 Sep 2.

DOI:10.1016/j.jhep.2009.08.003
PMID:19748698
Abstract
摘要

相似文献

1
Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence.乙型肝炎相关肝细胞癌的复发风险：病毒载量对晚期复发的影响。
J Hepatol. 2009 Nov;51(5):842-4. doi: 10.1016/j.jhep.2009.08.003. Epub 2009 Sep 2.
2
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.乙肝相关性肝细胞癌早期及晚期复发的危险因素。
J Hepatol. 2009 Nov;51(5):890-7. doi: 10.1016/j.jhep.2009.07.009. Epub 2009 Jul 23.
3
Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.乙型肝炎病毒基因混合体、C2和B2亚基因型在肝细胞癌中的作用：与同一地区慢性乙型肝炎和无症状携带者状态的比较。
Carcinogenesis. 2008 Sep;29(9):1685-91. doi: 10.1093/carcin/bgm301. Epub 2008 Jan 12.
4
HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles.乙肝病毒基因型与慢性乙型肝炎的临床结局：事实与谜题
Gastroenterology. 2008 Apr;134(4):1272-3; author reply 1273. doi: 10.1053/j.gastro.2007.12.046.
5
Hepatocellular carcinoma and hepatitis B virus.肝细胞癌与乙型肝炎病毒
Semin Liver Dis. 2006 May;26(2):153-61. doi: 10.1055/s-2006-939753.
6
Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.乙型肝炎相关肝细胞癌的复发与切除时的高病毒载量有关。
Am J Gastroenterol. 2008 Jul;103(7):1663-73. doi: 10.1111/j.1572-0241.2008.01872.x. Epub 2008 Jul 4.
7
High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma.血清透明质酸和 HBV 病毒载量高是乙型肝炎相关小肝细胞癌完全射频消融后局部复发的主要预后因素。
Ann Surg Oncol. 2012 Apr;19(4):1284-91. doi: 10.1245/s10434-011-2042-3. Epub 2011 Sep 13.
8
Stemming the tide of hepatitis B virus related hepatocellular carcinoma?
J Clin Oncol. 2008 Jan 10;26(2):172-4. doi: 10.1200/JCO.2007.14.4337.
9
The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.接受经动脉化疗栓塞术的肝细胞癌患者中，乙肝病毒载量对完全坏死术后复发的影响：对病毒抑制以降低癌症复发风险的意义。
Cancer. 2007 Oct 15;110(8):1760-7. doi: 10.1002/cncr.22984.
10
Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.慢性乙型肝炎病毒感染者肝细胞癌风险的列线图。
J Clin Oncol. 2010 May 10;28(14):2437-44. doi: 10.1200/JCO.2009.27.4456. Epub 2010 Apr 5.

引用本文的文献

1
A Novel Nomogram for the Preoperative Prediction of Edmondson-Steiner Grade III-IV in Hepatocellular Carcinoma Patients.一种用于术前预测肝细胞癌患者Edmondson-Steiner III-IV级的新型列线图。
J Hepatocell Carcinoma. 2023 Aug 23;10:1399-1409. doi: 10.2147/JHC.S417878. eCollection 2023.
2
The burden of Hepatitis B virus infection in Kenya: A systematic review and meta-analysis.肯尼亚乙型肝炎病毒感染负担：系统评价和荟萃分析。
Front Public Health. 2023 Jan 26;11:986020. doi: 10.3389/fpubh.2023.986020. eCollection 2023.
3
Recurrence Patterns After Hepatectomy With Very Narrow Resection Margins for Hepatocellular Carcinoma.
肝细胞癌肝切除术后切缘极窄时的复发模式
Front Surg. 2022 Jul 12;9:926728. doi: 10.3389/fsurg.2022.926728. eCollection 2022.
4
Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study.肝细胞癌患者术后特定时期复发风险作为监测策略框架的多中心结局研究
Liver Cancer. 2021 Sep 17;11(2):141-151. doi: 10.1159/000518837. eCollection 2022 Apr.
5
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?慢性病毒性肝炎相关肝细胞癌：我们的现状如何？
Int J Mol Sci. 2022 Jan 2;23(1):500. doi: 10.3390/ijms23010500.
6
The JAK/STAT signaling pathway: from bench to clinic.JAK/STAT 信号通路：从基础到临床。
Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1.
7
Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis.切除术后肝细胞癌辅助治疗的比较效果：一项系统评价和网状Meta分析
Front Oncol. 2021 Sep 2;11:709278. doi: 10.3389/fonc.2021.709278. eCollection 2021.
8
Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.预测原发性根治性治疗后早期肝细胞癌长期预后的因素：手术或非手术方法的作用。
BMC Cancer. 2021 Mar 8;21(1):250. doi: 10.1186/s12885-021-07948-9.
9
STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.STK39 是一种新型激酶，通过 PLK1/ERK 信号通路促进肝细胞癌的进展。
Theranostics. 2021 Jan 1;11(5):2108-2122. doi: 10.7150/thno.48112. eCollection 2021.
10
Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma.肝细胞癌完全治愈后复发模式和预测因素的时间变化。
Gut Liver. 2021 May 15;15(3):420-429. doi: 10.5009/gnl20101.